loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE

    Menu

    3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 161,827Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22522 / DOSAGE - TABLET;ORAL - 250MCG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    roflumilast(UNII: 0P6C6ZOP5U)
    (roflumilast - UNII:0P6C6ZOP5U)     		roflumilast500ug

    Inactive Ingredients

    Ingredient Name
    Strides Pharma Science Limited
    ALLERGAN, INC.
    Cardinal Health
    HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)  
    lactose monohydrate(EWQ57Q8I5X)
    magnesium stearate(70097M6I30)
    povidone(FZ989GH94E)  
    POVIDONE, UNSPECIFIED(FZ989GH94E)  
    STARCH, CORN(O8232NY3SJ)